By now, one hardly needs to stress the importance of solar UVR in the etiology of cutaneous squamous and basal cell carcinomas. What is less well understood, however, is the nature and magnitude of variables that influence the effectiveness of a given cumulative exposure in eliciting the tumor response in a susceptible population (let alone in a given individual).
The concern with emollients is not altogether new. Over several decades, a substantial number of published papers from clinical studies have suggested that there is a small but measurable influence of applied vehicles on cutaneous response to UVR exposure. For example, clinical data indicate that "application of typical cosmetic moisturizers containing 10% mineral oil or 10% glycerin decreased average MED (minimum erythemal dose) 5 or 7.6%, respectively" (TKL Research, 1995) . Demonstrating differences of such magnitude would require a large sampling base, and the differences would almost certainly be undetectable in studies involving limited numbers of individuals.
Although cosmetic creams and oils appear to enhance UVR penetration to a small degree, the heavier greases may have the opposite effect in human skin. For example, Schleider et al. (1979) observed that peanut oil and corn oil had no effect, mineral oil and Alpha Keri bath oil had a minimal effect, and Vaseline or petrolatum substantially reduced the effectiveness of UVR in eliciting erythema.
A physical-optical basis for a vehicle's effects in human skin has been described by Parrish (1981, 1982) . They indicated that prolonged application of water or aqueous media to normal Caucasian skin results in an "increase in transmittance of UV... [and] an increase in sensitivity...with a 40-50% decrease in MED...in contrast, lipophylic substances such as mineral oil neither extract significant amounts of UV-absorbing material...nor affect the MED to UVB radiation when applied in vivo." They also conclude that "mineral oil, which readily spreads over the surface of skin...does little to reduce reflectance" (or increase penetration) in normal skin, but may have some effect in the thicker corneum of psoriatic plaque. In contrast, Hudson-Peacock et al. (1994) found a greater epidermal transmission of UVR in vitro after application of some oily substances.
Moisturizers, Vehicle Effects, and Photocarcinogenesis
Paul Donald Forbes Leroy et al. (1986) measured changes in the transmission spectrum through untreated versus oiled dried suction blister epidermis (they apparently did not also investigate hydrated suction blister epidermis). The investigators claimed that the in vitro findings were consistent with better psoriatic clearing clinically. Gahard et al. (1996) proposed that emollients changed the skin response enough to make a substantial difference to the patients undergoing phototherapy. Leroy et al. (1986) reported increased penetration by high-intensity UV rays following the application of Vaseline oil. Schleider et al. (1979) found a minimal effect by lighter oils and some protection by heavier greases such as petrolatum. Farr et al. (1983) provided evidence of vehicle-induced increase in in vivo transmission of light through psoriatic plaques, including a twofold transmission increase with glycerin.
As indicated by Lu and colleagues (2009, this issue), Kligman and Kligman (1992) found protection by Vaseline against both acute and chronic effects of UVR, including tumorigenesis, but they reported substantial enhancement of acute photoirritation as well as tumorigenesis by mineral oil. Although they acknowledged some optical effect by emollients, they disclaimed the idea that the effect was entirely physical/optical.
Taken together, the published data provide substantial evidence that some vehicles, particularly the lighter oils, enhance penetration of UVR into mouse skin, leading to a greater cutaneous response-sometimes nearly doubling the effectiveness of a UVR dose. A qualitatively similar effect is sometimes evident in human skin, but the enhancement is usually marginal.
| Are seemingly innocuous formulations invariably innocuous?
Prior to the report by Lu et al., little attention was paid to the possibility of a post-UVR effect by these seemingly innocuous formulations. Their paper raises the question of whether these agents belong on a list of more active compounds analogous to tumor promoters (in two-stage carcinogenesis, in which UVR is the initiator; see Forbes et al., 1979; Sambuco and Forbes, 1983) . Beyond the interest in Lu and colleagues' challenging laboratory data is the obvious question of relevance to humans. Animal studies are critical to hazard identification but are still lacking as a risk-assessment tool (Forbes and Sambuco, 1988) . More specifically, for such studies to provide guidance on estimating the possible impact on humans, dose-response ("calibration") treatment groups are needed with which to calculate "potency factors" (Forbes et al., 2003) . When available, calibration treatment groups provide a dynamic range of responses to UVR alone, permitting accurate interpolation and reasonable extrapolation for data from the groups also receiving the test agents. If significant differences are found between treatment groups and the corresponding calibration group, then calculating a scaling factor or potency ratio may provide a measure of the effectiveness of each treatment, i.e., an estimated ratio of UVR doses to produce the same response (Forbes et al., 2003) . Restated, deviations from a "zero-effect" level in tumor response can be expressed in terms of a potency factor (i.e., expressed as the mathematical equivalent of changing the UV dose by a specified fraction). One can only hope that such experimental data will become available from additional studies, particularly in view of the findings of Lu et al. (2009) .
Clinical data that can be used to evaluate the possible relevance of Lu and colleagues' findings to humans will not be easy to extract, although an analogous question about another type of interaction was answered recently by Karagas et al. (2007) . They presented evidence that the use of recognized photosensitizing agents can increase skin cancer incidence in patients requiring these mediations (as compared with others in the general population). Their approach may suggest a methodology for use in the current context. Mott LA, Sorensen HT et al. (2007) 
